Potential in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

... strategic efforts, including the introduction or potential introduction of generic or competing products ... intellectual property rights by actual or potential competitors or to the Company's ability to market ... challenges to other companies' introduction or potential introduction of generic or competing products by ...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... continue to advance discussions with a number of potential partners for our 12-hour controlled release ibuprofen. These potential partners have been committing resources to due ... continue to work with our investment bankers on potential strategic transactions, including mergers and ...

NeurogesX Reports Second Quarter 2009 Results

... and remains in active discussions regarding a potential U.S. co-promotion agreement. Anthony ... on track, assuming an approval in November, for a potential U.S. launch of Qutenza in the first half of 2010. ... and we are now focusing our resources on the potential for U.S. commercialization as our PDUFA date ...

Synthetech Reports First Quarter Fiscal 2010 Results

... to predict the progress, timing and revenue potential of these projects. About Synthetech ... the uncertain market for Synthetech's products; potential loss of a significant customer; customer concentration; potential termination or suspension by customers of ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... the strongest possible file that positions us for potential approval in the first review cycle. Our ... There were no remarkable safety findings. The potential product and patient benefits of the ritonavir ... InterMune to additional risks where it may lose potential revenue. The risks and other factors discussed ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... may provide for more substantial revenue growth potential as compared to our overall product portfolio. Our ... the Option IVC Filter may have a number of potential competitive benefits, which include a unique filter design that may reduce the potential for filter migration after implantation, thereby ...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... by developing innovative products that have the potential to markedly improve patients' lives." ... of the protein frataxin which may have the potential to arrest disease progression in patients with Friedreich's ataxia. We have identified several potential clinical candidates and are further ...

Exciton Technologies receives FDA approval to market exSALT(TM)

... a year. Exciton's silver-based products have the potential to capitalize an even larger market by: ... including the Company's belief as to the potential of its products, the Company's expectations ... to economically manufacture its products, the potential of its products, the success and timely ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... continues to invest in research to assess the potential for applying its versatile chaperone technology ... discussions with regulatory authorities and the potential goals, progress, timing and results of ... of Amicus, including, without limitation: the potential inability to reach final agreement with ...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... and believe that Acetavance has significant potential to enhance patient care." Also during the ... new products, which could diminish the commercial potential for Acetavance; the possibility that the patent ... from being developed by competitors; the potential for Cadence to require substantial additional ...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

... This research agreement will explore the potential of using IVT's DepoVax(TM) delivery system for ... R D at IVT. "Our DepoVax(TM) technology has the potential to better deliver DNA vaccines to draining lymph ... clinic, their relative ease of manufacture and potential for enhanced stability. There is currently a need ...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

... patients and thus gain more information about the potential long-term effects of CERE-120 on Parkinson's ... our data base. Our conviction about CERE-120's potential to treat Parkinson's disease remains strong. We ... us to design a protocol that should maximize the potential for the greatest treatment effect in our upcoming ...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

... clinical trials play a crucial role in evaluating potential therapeutic treatments for many critical health ... statements include product development, product potential projections and estimates and their underlying ... that could affect the availability or commercial potential of such products candidates, the absence of ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... primary business goal is to maximize the revenue potential of our flavor ingredients. We believe Senomyx's ... solutions for a variety of products." The potential market for Senomyx's Sweet Enhancers includes a ... and the possibility of addressing the needs of potential new collaborators." Senomyx is also ...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

... working with Firmenich to maximize the commercial potential of our new Sweet Enhancers," said Kent Snyder, ... and Rebaudioside (stevia); the capabilities and potential uses of Senomyx's flavor ingredients; Senomyx's ... and the speed of commercialization, revenue potential and market acceptance of sweet enhancing flavor ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... Administration (FDA), Intermezzo ((R)) has the potential to be the first prescription sleep aid ... We believe that Intermezzo ((R)) has the potential to occupy an important position in the ... Our agreement with Purdue establishes the potential for a substantial Transcept revenue stream, and ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

... has significant therapeutic and commercial potential as a novel agent to combat CAP as well as other ... In addition to developing Restanza as a potential treatment for CAP, Advanced Life Sciences has ... and penicillin resistance grows and has the potential to cause more clinical failures, there is a need ...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... intends to explore partnership opportunities as a potential path to continue the development of ANA773. ... C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of ... plans to explore partnership opportunities as a potential path to continue the development of ANA773. Such ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... believes that future DNA-based products offer the potential to provide patients and healthcare systems with ... variant of BMP-4 (chBMP4), which offers the potential for the localized and sustained cellular ... as bone repair. Cardium plans to explore potential collaborations with other companies in the ...

Cornerstone Therapeutics Announces Closing of Chiesi Transaction

... life cycle management strategies to maximize the potential value and competitive position of the Company's ... Our forward-looking statements do not reflect the potential impact of any acquisitions, mergers, ... as specifically indicated we may address the potential impact of our transaction with Chiesi. These ...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

... reinforce our belief that REOLYSIN has the potential to significantly improve treatment outcomes in ... on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program ... including the Company's belief as to the potential of REOLYSIN as a cancer therapeutic; the ...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration

... in the research, development and licensing of the potential drug candidate Homspera and its derivatives ... on the development of these drug candidates as potential treatments for blood disorders and to accelerate ... for these compounds as a vaccine adjuvant and potential treatment for influenza or other microbial ...

Sanofi-aventis Announces Second Quarter 2009 Results

... inconsistent and inconclusive results regarding a potential link between Lantus ((R)) use and an increased ... statements include product development, product potential projections and estimates and their underlying ... that could affect the availability or commercial potential of such products candidates, the absence of ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... or GAM(TM) technology for ulcers and other potential applications, including not only the repair of ... regarding the use of Excellarate for the potential treatment of diabetic foot ulcers and other potential GAM product candidates is expected to be reported ...

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

... denosumab in Japan in PMO and oncology with the potential for additional indications. This arrangement ... RANK Ligand and is being investigated for its potential to prevent and treat a broad range of bone ... illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to ...

Independent Study Confirms Superior Properties of ZPC(TM) Enhanced Calcium Composite Bone Grafts

... properties due to its unique negative zeta potential control (ZPC(TM)). The research carried ... and Regensburg, Germany, analysed the osteogenic potential of Fortoss Vital for maxillary sinus ... calcium composite material with a negative Zeta potential for bone augmentation." Head & face ...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... future preclinical and clinical development and potential product commercialization. Peregrine will ... maintain an interest in the significant upside potential of the anti-VEGF program. This agreement fits ... against the drug itself, thereby lessening the potential for immunological side effects and neutralization ...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... and turned into a bioterrorist weapon with the potential to cause significant loss of life. With ... darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and ... currently in Phase 3 development as a potential treatment for type 2 diabetes. For more ...

Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System

... development of new clinical therapies with the potential to improve diagnosis and treatment of a wide ... monitoring from as many as 256 channels, with the potential to be scalable to more than a thousand channels ... (ECG), electrooculography (EOG) and Evoked potential (EP). The NeuroPort System provides ...

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies

... worldwide license to develop the antibodies for potential therapeutic, diagnostic and prophylactic use, and ... antibodies, peptides and small molecules with potential applications in the treatment of cancer and ... of CII. "This agreement with Morphotek has the potential for the development of new drug candidates for ...

Vasogen Announces Second Quarter 2009 Results

... screening, reviewing, and short-listing potential opportunities, including the sale of the ... process has also included a review of the potential out-licensing of assets, lapsing of ... of our programs, on capital availability, the potential dilutive effects of any financing and other risks ...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

... of Alzheimer's Disease and Evaluate the Impact of potential Interventions (Colantuoni E, et al.) More ... and policy makers who are evaluating the potential impact of interventions that may reduce disease ... initiated in December 2007 for bapineuzumab as a potential treatment for patients with mild to moderate ...

Novel method predicts impact of a covert anthrax release

... a new way to forecast the future course of a potential outbreak and the people and geographic areas likely to be worst affected." Anthrax has the potential to cause a large number of deaths in the event of ... decision makers to evaluate its extent and the potential impact on the population and then to identify the ...

Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax

... efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug ... on these results, we believe raxibacumab has the potential to be a significant step forward in the treatment ... darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and ...

Novel handheld device detects anthrax with outstanding accuracy and reliability

... results from a system that has so much potential to reduce the large costs and losses in ... on average one alert a day or more regarding the potential presence of anthrax, so this device can only ... new testing results are expected to unlock large potential markets for Veritide in North America and around ...

Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments

... life cycle management strategies to maximize the potential value and competitive position of Cornerstone's ... life cycle management strategies to maximize the potential value and competitive position of the Company's ... Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. ... the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin ... received; or manufacturing and supply issues. The potential for BYETTA and/or exenatide once weekly may also ...

CEL-SCI Corporation Releases Letter to Shareholders

... the unstoppable nature of swine flu and its potential to mutate - "Constant, random mutation is the ... flu in Egypt or elsewhere in the world has the potential to be particularly lethal especially if it is ... in clinical studies, timely development of any potential products that can be shown to be safe and ...

Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome

... Lexicon's clinical development of LX1032 and the potential therapeutic and commercial potential of LX1032. This press release also contains ... preclinical and clinical development of its other potential drug candidates, advance additional candidates ...

Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration

... novel marine microbial compounds that have potential as tools for biological research and ultimately ... novel marine microbial compounds that have potential as tools for biological research and ultimately ... will then optimize novel compounds to afford potential biological probes and preclinical drug ....